Cite
HARVARD Citation
Fernando, S. et al. (n.d.). ATwo-Centre Audit on Changes in Ejection Fraction (EF) following sequential anthracycline chemotherapy and Trastuzumab (T) in patients with HER2+ Early Breast Cancer (EBC). Breast. pp. S128-. [Online].